专利检索 ap:("THE ASEAN FOUNDATION" OR "DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION" OR "UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION") AND inv:"Dong Eun KIM" 第 1 页

1.

发明公开
QUINAZOLINE-2,4-DIAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 审中-公开

公开(公告)号：US20230365530A1

公开(公告)日：2023-11-16

申请号：US18246178

申请日：2021-09-16

申请人： THE ASEAN FOUNDATION , DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION , UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION

发明人： Jung Jin HWANG , Sang Eun PARK , Dong Eun KIM , Ji-Ye HONG , Choung-Soo KIM , Woo Chan SON , Shinae KIM , Sugyeong KWON , Kyungjin JUNG , Nayeon KIM , Jina KIM , Kyung-Hee KIM , Jung Wook CHIN , Sung Jin CHO , Sehan LEE , Eunju CHA , Jeongmin JOO , Ji Sun HWANG , Jeong-Eun PARK , Ji Hoon YU , Eunmi HONG , Young-Hoon PARK , Ju-Hee LEE

IPC分类号： C07D401/14 , A61K45/06 , A61P35/00 , C07D401/12 , C07D239/95

CPC分类号： C07D401/14 , A61K45/06 , A61P35/00 , C07D401/12 , C07D239/95

摘要： A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.